Citus AG

Citus AG, an ETH Zurich spinoff, is revolutionizing the beauty-tech market with its flagship product, NIMBLE. This patented device enables real-time, non-invasive skin analysis, addressing the growing demand for personalized skincare solutions supported by scientific data. Initially developed for medical diagnostics, NIMBLE is now primed to disrupt the beauty industry by offering a unique value proposition to both consumers and skincare brands.
The global skin care market reached 120 billion CHF in 2022, where 38% of revenue was generated through sales at retail stores, equaling 45 billion CHF. An increasing emphasis on overall wellness and skin health is driving demand for personalized skincare solutions, resulting in one of the fastest growing markets at the moment.